Practice pay vs. patient pay: Choosing a billing model that works for your practice

Every prescriber working with a compounding pharmacy faces the same operational decision: does your patient pay the pharmacy directly, or does your practice purchase the medication and dispense it yourself?

Both models work and both come with tradeoffs. The problems truly arise when you try to run both.

Which of the two billing models best fits your practice depends on your practice size, patient volume, cash flow tolerance, and how much control you want over the patient experience.

Patient pay vs practice pay: How each model works

A quick overview of both models before we compare the two.

Patient pay

The practice writes the prescription. The compounding pharmacy fulfills it and collects payment directly from the patient. The practice never touches the medication or the transaction.

Practice pay

The practice purchases medication from the pharmacy at wholesale or volume-tiered pricing, stores it on-site, and dispenses directly to patients at a markup. The practice owns the inventory, sets the price, and controls the full transaction.

The case for patient pay: you prescribe. Someone else handles the rest.

Patient pay is operationally simple with no inventory management, upfront capital outlay, storage, or expiration tracking. Inventory carrying costs alone can account for 20-30% of inventory value annually. For instance, for $50,000 in compounded medications, you may need to spend $10,000 – $15,000 to just maintain stock properly as well as account for expiration, shrinkage, storage, insurance, and the like.

The pharmacy handles fulfillment, shipping, payment collection, and in many cases, fielding patient questions about their orders.
That last point matters more than it looks on paper. When patients have questions about their medication, shipping status, or refill timing, those calls go to the pharmacy or its support team instead of your front desk. You don’t need to staff around that call volume.

Lower risk, faster launch

There’s virtually no setup once you’ve got an established pharmacy partner. You prescribe, the pharmacy fulfills, the patient pays. For practices adding a new treatment category like peptides or GLP-1s, patient pay lets you test demand without committing capital to inventory you may not move.

Compliance is simpler

Dispensing regulations vary greatly by state with 32 boards of pharmacy requiring full compliance with USP Chapter <797> while another 11 have separate and equal, or sometimes stricter standards than <797>. Patient pay sidesteps most dispensing licensure requirements because the practice isn’t acting as a dispensary.

The tradeoff is revenue

Under patient pay, you collect for the visit and any ancillary services. The medication margin goes to the pharmacy. When patients are spending $1,300 to $4,200 per year on TRT alone, that’s meaningful revenue your practice never touches.

The case for practice pay

You capture the full transaction

Maintaining a relationship with a compounding pharmacy and dispensing at a retail markup creates a direct revenue line on every prescription. Typically, compounding pharmacies who offer bulk ordering will offer lower pricing for the guaranteed order volume. Multiply that margin across a full panel of patients on TRT, GLP-1 protocols, and peptide therapy, and the gap between models becomes significant.

You own the patient experience

When patients get their medication from you, there’s no confusion about where to order, no shipping delays they blame on your clinic, and no third-party layer between you and your patient. That control strengthens retention.

Recurring revenue you can forecast

For treatments requiring monthly refills, practice pay gives you a predictable revenue line. You know your purchase cost. You set your dispensing price. Monthly medication revenue becomes something you can forecast with precision.

The tradeoff is operational burden

Practice pay means you own everything downstream of the prescription. Having visibility into available inventory from your pharmacy partner and patient billing all sit with your team.

While working with a 503c pharmacy partner does usually translate to cheaper pricing, you then have to manage dispensing, licensure, and the like.

More importantly, you’re now the point of contact for medication questions. Patients call your office about refill timing, shipping, dosing confusion, and side effects. That requires staffing, phone coverage, and patient education infrastructure that patient pay offloads entirely.

There’s a third option

Some practices want the margin advantage of practice pay without the operational burden of storing and dispensing bulk medication in-office. A bill-practice, ship-to-patient model splits the difference.

How it works

Working with partners like Evitalin, your practice prescribes medication through our pharmacy partner’s formulary but you handle the patient billing directly. The pharmacy ships the product straight to your patient’s door and your practice never stores inventory, manages expiration tracking, or navigates state dispensing requirements.

Why it works

You capture the medication margin because the billing relationship sits with your practice. But you offload the logistics. The pharmacy handles fulfillment, shipping, and the physical product chain. Your team focuses on clinical care and patient billing, not inventory procurement and cold storage.

For practices built around recurring treatments like TRT, GLP-1 protocols, and peptide therapy, this model scales cleanly. You get predictable medication revenue without the warehouse overhead.

This combination means that this model of the three is likely the easiest to scale while also maintaining maximum profitability.

The tradeoff

You’re still managing the patient billing side. That means invoicing, payment collection, and fielding billing questions from patients.

You also own the pricing conversation, which requires transparency about what patients are paying and what’s included. Similarly, patients are more likely to come to you with any questions assuming your pharmacy partner doesn’t have a support system built in.

But compared to full practice pay, the operational footprint is significantly smaller. And compared to patient pay, the revenue ceiling is significantly higher.

The worst option is doing multiple versions

Some practices end up running a combination of both by accident.

Half their patients are on patient pay because of legacy pricing structures, referral deals, or promotional programs. The other half are on practice pay because the margins are better.

This creates the worst of both worlds. Your team manages two parallel billing workflows. Your inventory planning is unreliable because only a fraction of patients flow through your dispensing model.

Your staff fields some patient medication questions but not others, with no clean system for routing. Pricing inconsistencies between the two groups create confusion and, eventually, complaints.

If you’re running a hybrid right now, that’s the first thing to fix.

Deciding which model fits your practice

Choose patient pay if:

• You’re early-stage or testing a new treatment line and want to minimize operational risk
• Your team is lean and you can’t staff around medication fulfillment and patient support
• You’d rather invest time in clinical care than inventory management and billing logistics
• You operate in a state with complex dispensing regulations you’d prefer to avoid

Choose practice pay if:

• You have consistent patient volume and predictable demand across your core treatments
• You want to maximize per-patient revenue and can absorb the upfront inventory investment
• You have the infrastructure to handle medication storage, dispensing compliance, and patient inquiries
• You’re prepared to own the full patient experience from visit through medication delivery

Choose bill-clinic, ship-patient if:

• You want to capture medication margins but don’t want to store, track, or dispense inventory on-site
• Your practice is growing and you need a model that scales without adding fulfillment staff or storage space
• You want patients to receive medication at their door without losing the billing relationship with your office
• You’d rather keep your team focused on clinical care than logistics

Making the switch

Moving to patient pay

Start by identifying which patients are lowest-friction to transition. Patients on stable, recurring prescriptions with predictable refill cycles can shift to pharmacy-direct billing with minimal disruption.

Communicate the change as a simplification, not a downgrade.

The patient still gets the same medication, prescribed by you, with the added convenience of pharmacy-managed fulfillment and support.

Moving to practice pay

Begin with your highest-volume prescriptions.

TRT and GLP-1 medications with consistent monthly demand are the best candidates because predictable volume reduces the risk of sitting on unused inventory.

Negotiate volume-based pricing with your pharmacy partner so that margins improve as you scale. Build the workflow cleanly with a small cohort before expanding.

Moving to bill-clinic, ship-patient

The model requires a pharmacy partner that can deliver on both sides: competitive wholesale pricing for your practice and reliable direct-to-patient shipping.

Evitalin’s network gives you access to established pharmacy partners, volume-based pricing, and a ship-to-patient infrastructure that’s already built. You bring the patients and the clinical expertise. The fulfillment side is handled.

Request a catalog to explore the full formulary and find the right fit for your billing model.

Regardless of direction, don’t phase it

The instinct is to grandfather existing patients and only apply the new model to new ones.

Resist that.

A split model is what creates the operational headaches you’re trying to solve. Set a transition date, communicate it clearly, and move everyone at once.

Pick the model that fits your team, your volume, and your growth plan. Then commit to it fully.

Build your billing model on the right foundation with Evitalin

The billing model only works if the economics behind it do. That starts with your pharmacy partnership.

Evitalin connects practices with a vetted compounding pharmacy partner in PharmaLabs, pricing that protects your margins, and operational support designed to make whichever model you choose run cleanly.

Whether you’re billing patients directly, purchasing and dispensing in-office, or running a bill-practice, ship-to-patient model, the formulary access and pricing structure need to support your margins from day one.

Explore the full formulary and request a catalog to see how the numbers work for your practice.